These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 16702006)

  • 21. Body composition and quality of life in adults with growth hormone deficiency; effects of low-dose growth hormone replacement.
    Ahmad AM; Hopkins MT; Thomas J; Ibrahim H; Fraser WD; Vora JP
    Clin Endocrinol (Oxf); 2001 Jun; 54(6):709-17. PubMed ID: 11422104
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Growth hormone deficiency in adults: effects of replacement therapy on body composition and health-related quality of life].
    Mesa J; Gómez JM; Hernández C; Picó A; Ulied A;
    Med Clin (Barc); 2003 Jan; 120(2):41-6. PubMed ID: 12570912
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Circulating IGF-I levels in monitoring and predicting efficacy during long-term GH treatment of GH-deficient adults.
    Ezzat S; Fear S; Gaillard RC; Gayle C; Marcovitz S; Mattioni T; Nussey S; Rees A; Svanberg E
    Eur J Endocrinol; 2003 Dec; 149(6):499-509. PubMed ID: 14640990
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Growth hormone therapy does not alter the insulin-like growth factor-I/insulin-like growth factor binding protein-3 molar ratio in growth hormone-deficient children.
    Scirè G; Del Bianco C; Spadoni GL; Cianfarani S
    J Endocrinol Invest; 2008 Feb; 31(2):153-8. PubMed ID: 18362507
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intersubject responsiveness of high-affinity growth hormone (GH)-binding protein (GHBP) to long-term GH replacement therapy.
    De Vries WR; Koppeschaar HP; Bol E; Roelen CA; Donker GH; Doerga ME; Osman-Dualeh M; Snel YE
    J Endocrinol Invest; 2000; 23(7):449-56. PubMed ID: 11005269
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monitoring serum insulin-like growth factor-I (IGF-I), IGF binding protein-3 (IGFBP-3), IGF-I/IGFBP-3 molar ratio and leptin during growth hormone treatment for disordered growth.
    Tillmann V; Patel L; Gill MS; Whatmore AJ; Price DA; Kibirige MS; Wales JK; Clayton PE
    Clin Endocrinol (Oxf); 2000 Sep; 53(3):329-36. PubMed ID: 10971450
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of growth hormone replacement on physical performance and body composition in GH deficient adults.
    Rodríguez-Arnao J; Jabbar A; Fulcher K; Besser GM; Ross RJ
    Clin Endocrinol (Oxf); 1999 Jul; 51(1):53-60. PubMed ID: 10468965
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Growth hormone treatment of osteoporotic postmenopausal women - a one-year placebo-controlled study.
    Sääf M; Hilding A; Thorën M; Troell S; Hall K
    Eur J Endocrinol; 1999 May; 140(5):390-9. PubMed ID: 10229902
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gender-specific responses of lean body composition and non-gender-specific cardiac function improvement after GH replacement in GH-deficient adults.
    Ezzat S; Fear S; Gaillard RC; Gayle C; Landy H; Marcovitz S; Mattioni T; Nussey S; Rees A; Svanberg E
    J Clin Endocrinol Metab; 2002 Jun; 87(6):2725-33. PubMed ID: 12050241
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endocrine and metabolic effects of long-term administration of [Nle27]growth hormone-releasing hormone-(1-29)-NH2 in age-advanced men and women.
    Khorram O; Laughlin GA; Yen SS
    J Clin Endocrinol Metab; 1997 May; 82(5):1472-9. PubMed ID: 9141536
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Growth hormone decreases visceral fat and improves cardiovascular risk markers in women with hypopituitarism: a randomized, placebo-controlled study.
    Beauregard C; Utz AL; Schaub AE; Nachtigall L; Biller BM; Miller KK; Klibanski A
    J Clin Endocrinol Metab; 2008 Jun; 93(6):2063-71. PubMed ID: 18381581
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-affinity growth hormone (GH)-binding protein (GHBP), body fat mass, and insulin-like growth factor-binding protein-3 predict the GHBP response to GH therapy in adult GH deficiency syndrome.
    Roelen CA; Koppeschaar HP; de Vries WR; Doerga ME; Snel YE; Bol E; Zelissen PM; Thijssen JH; Blankenstein MA
    Metabolism; 1999 Mar; 48(3):314-8. PubMed ID: 10094106
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Short-term safety and efficacy of human GH replacement therapy in 595 adults with GH deficiency: a comparison of two dosage algorithms.
    Kehely A; Bates PC; Frewer P; Birkett M; Blum WF; Mamessier P; Ezzat S; Ho KK; Lombardi G; Luger A; Marek J; Russell-Jones D; Sönksen P; Attanasio AF
    J Clin Endocrinol Metab; 2002 May; 87(5):1974-9. PubMed ID: 11994327
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Amino acid profiles in adults with growth hormone (GH) deficiency before and during GH replacement therapy.
    Fernholm R; Thoren M; Hoybye C; Anderstam B; Pernow Y; Saaf M; Hall K
    Growth Horm IGF Res; 2009 Jun; 19(3):206-11. PubMed ID: 18990596
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Growth hormone (GH) effects on central fat accumulation in adult Japanese GH deficient patients: 6-month fixed-dose effects persist during second 6-month individualized-dose phase.
    Chihara K; Shimatsu A; Kato Y; Kohno H; Tanaka T; Takano K; Irie M
    Endocr J; 2006 Dec; 53(6):853-8. PubMed ID: 17001106
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Limited efficacy of growth hormone (GH) during transition of GH-deficient patients from adolescence to adulthood: a phase III multicenter, double-blind, randomized two-year trial.
    Mauras N; Pescovitz OH; Allada V; Messig M; Wajnrajch MP; Lippe B;
    J Clin Endocrinol Metab; 2005 Jul; 90(7):3946-55. PubMed ID: 15855257
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of a combination of recombinant human growth hormone with metformin on glucose metabolism and body composition in patients with metabolic syndrome.
    Herrmann BL; Berg C; Vogel E; Nowak T; Renzing-Koehler K; Mann K; Saller B
    Horm Metab Res; 2004 Jan; 36(1):54-61. PubMed ID: 14983408
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Discontinuing long-term GH replacement therapy--a randomized, placebo-controlled crossover trial in adult GH deficiency.
    Filipsson Nyström H; Barbosa EJ; Nilsson AG; Norrman LL; Ragnarsson O; Johannsson G
    J Clin Endocrinol Metab; 2012 Sep; 97(9):3185-95. PubMed ID: 22791760
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Growth hormone replacement therapy improves body composition and increases bone metabolism in elderly patients with pituitary disease.
    Fernholm R; Bramnert M; Hägg E; Hilding A; Baylink DJ; Mohan S; Thorén M
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4104-12. PubMed ID: 11095440
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recombinant human growth hormone treatment in elderly patients undergoing elective total hip replacement.
    Weissberger AJ; Anastasiadis AD; Sturgess I; Martin FC; Smith MA; Sönksen PH
    Clin Endocrinol (Oxf); 2003 Jan; 58(1):99-107. PubMed ID: 12519419
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.